Beta Bionics BBNX
NASDAQ BBNX
$18.96 +0.09 (+0.48%)
At close: Oct 2, 2026 · 4:00 PM EDT

Beta Bionics (BBNX) Return on Capital Employed [ROCE] (2025 - 2026)

Updated

Beta Bionics (BBNX) reported Return on Capital Employed [ROCE] of -30.48% for Q2 2026, down 10.60 percentage points from -19.88% a year earlier and down 4.13 percentage points from the prior quarter.

Analysis

Beta Bionics (BBNX) Return on Capital Employed [ROCE] (2025 - 2026) Analysis & Trends

For FY2025, Beta Bionics posted Return on Capital Employed [ROCE] of -34.42%, up 7.21 percentage points from FY2024.

  • By year, Return on Capital Employed [ROCE] came in at -41.63% in FY2024.
  • Per Business Quant data, the three quarters before Q2 2026 came in at -26.35% (Q1 2026), -24.02% (Q4 2025) and -22.52% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn 8.30%
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn 7.98%
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn 6.42%
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn 18.58%
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn 8.34%
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn 13.69%
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn 10.83%
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn 11.99%
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn 6.00%
10 Beta Bionics 852.85 Mn 25.03 Mn 18.90 Mn -30.48%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -30.48%
Mar 31, 2026 -26.35%
Dec 31, 2025 -24.02%
Sep 30, 2025 -22.52%
Jun 30, 2025 -19.88%
Mar 31, 2025 -23.95%
API Access

Beta Bionics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=BBNX&period=max&api_key=YOUR_API_KEY